Outlook Therapeutics (OTLK) Competitor Comparison
We are evaluating the key criteria listed to compare Outlook Therapeutics (OTLK) against its competitors in the Biotechnology industry.
Market Capitalization
255 / 368Gross Profits
190 / 278Total Revenue
0 / 300EBITDA
142 / 337Free Cashflow
147 / 352Quick Ratio
343 / 357Earnings per Share
316 / 359Dividend yield
0 / 6Total Cash
296 / 358Performance 3 years
258 / 368Performance 5 years
215 / 368Performance 10 years
328 / 368Linearity 3 years
139 / 368Linearity 5 years
95 / 368Linearity 10 years
302 / 368Total Rank
221 / 368Dividend Rank
231 / 368Valuation Rank
319 / 368Piotroski Rank
173 / 368Muliplier Rank
69 / 368Gross Profits - OTLK ranking 190 / 278
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.